Brand semaglutide
Sold by Evernow · Oral tablet · every brand semaglutide record
Price
No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.
We earn nothing from this link. It opens Evernow's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- October 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | The general terms prohibit returns of pharmaceutical medications and direct order problems to support. A GLP-1 membership cancellation deadline is not established on the reviewed pages. |
| Membership | Not disclosed |
| Consult fee | Not disclosed |
Recorded from evernow.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. October 2026 — Evernow explicitly lists Rybelsus among available prescription options, subject to clinical assessment. Rybelsus is branded semaglutide in oral tablets; its medicine price is separate from care and was not established in the reviewed catalog. https://www.evernow.com/care/weight-loss https://www.novo-pi.com/rybelsus.pdf
- 2. October 2026 — General care-options and video visit information: https://www.evernow.com/how-it-works . General pharmaceutical-return terms: https://www.evernow.com/legal/terms .
- 3. October 2026 — Evernow’s general care-options page advertises membership starting at $35 per month and membership-free visits with a menopause provider. Its weight-loss enrollment page asks patients to select a membership plan. Whether the per-visit option applies to GLP-1 care, and the required GLP-1 care fee, are not established by those pages. Medication costs are separate. https://www.evernow.com/how-it-works https://www.evernow.com/care/weight-loss
- 4. October 2026 — Evernow also mentions compounded GLP-1 alternatives in its shortage FAQ without identifying a specific molecule, preparation or price. The public description does not establish an additional named compounded program. https://www.evernow.com/prescription/weight-loss/ozempic
4 further notes concern other Evernow programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.